K. Sundarapandiyan

发表

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

James M. Boyer, L. Vitale, T. Keler, 2018, Cancer Immunology, Immunotherapy.

Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.

P. Wallace, T. Keler, R. Graziano, 1998, Journal of immunology.

Differential Effect of Cytokine Treatment on Fcα Receptor I- and Fcγ Receptor I-Mediated Tumor Cytotoxicity by Monocyte-Derived Macrophages

P. Wallace, L. Vitale, T. Keler, 2000, The Journal of Immunology.

Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy1

M. Glennie, J. Kalden, M. Gramatzki, 2000, The Journal of Immunology.

CD 20-Directed Antibody Therapy Neutrophils as Effector Cells for-Receptor I ( CD 89 ) Recruits α Triggering FC

M. Glennie, J. Kalden, F. Egmond, 2000 .

Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells.

T. Keler, R. Graziano, Y. Deo, 1999, Human antibodies.

Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1

James M. Boyer, P. Wallace, L. Vitale, 2016, Molecular Cancer Therapeutics.

Targeting Weak Antigens to CD64 Elicits Potent Humoral Responses in Human CD64 Transgenic Mice

L. Vitale, T. Keler, R. Graziano, 2000, The Journal of Immunology.

Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells.

S. Barth, T. Keler, R. Graziano, 2001, Journal of immunological methods.

Cytolytic and cytostatic properties of an anti-human Fc gammaRI (CD64) x epidermal growth factor bispecific fusion protein.

R. Graziano, Y. Deo, K. Sundarapandiyan, 1997, Journal of immunology.

Targeting tumor cell destruction with CD64-directed bispecific fusion proteins

T. Keler, R. Graziano, Y. Deo, 1997, Cancer Immunology, Immunotherapy.

Monocyte-Derived Macrophages I-Mediated Tumor Cytotoxicity by Receptor γ Receptor I-and Fc α Fc Differential Effect of Cytokine Treatment on and

P. Wallace, L. Vitale, T. Keler, 2000 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab

M. Bylesjo, T. Keler, H. Marsh, 2015, Journal of Immunotherapy for Cancer.

Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice

Afsheen Fatima, M. Ward, S. Gandhapudi, 2023, Viruses.

Abstract 1239: Characterization of the response of human T cells to an agonist human anti-CD27 mAb.

L. Vitale, T. Keler, T. O’Neill, 2013 .

Influence of the chemical nature of side chain at beta 108 of hemoglobin A on the modulation of the oxygen affinity by chloride ions. Low oxygen affinity variants of human hemoglobin expressed in transgenic pigs: hemoglobins Presbyterian and Yoshizuka.

B. Manjula, A. Acharya, K. Sundarapandiyan, 1994, The Journal of biological chemistry.

Development of a Human Anti-CD27 Antibody with Efficacy in Lymphoma and Leukemia Models by Two Distinct Mechanisms

L. Vitale, T. Keler, T. O’Neill, 2011 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.